ArticleWorld neurosurgery2025
Socioeconomic Factors Associate With Access but not Survival in Neurosurgical Brain Tumor Patients.
Article in World neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Inequitable access to neurosurgical care in the United States.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
objectiveDatabase studies have identified population-level differences in neurosurgical-oncological outcomes. This study aimed to clarify these distinctions by evaluating associations between patient sociodemographics and metrics of care access, utilization, and clinical outcomes.
methodsWe retrospectively reviewed a prospectively identified database of neurosurgical-oncology patients (n = 1476) over 5 years. We conducted pathology-specific, multivariate analyses to identify sociodemographics associated with access, utilization, and outcomes, then interviewed (n = 40) with newly diagnosed patients.
resultsSignificant associations were found between sociodemographics (White n = 911; Hispanic/Latino n = 285; Asian n = 206; Black n = 74), sex (ANOVA P = 0.0043), age (P < 0.001), income (P < 0.001), primary language (P < 0.001), and insurance (P < 0.001). Emergent presentation and time from imaging to neurosurgical consultation were associated with English as an additional language (EAL) (P = 0.03, P = 0.03) and public insurance (P = 0.003, P = 0.003). Black patients had increased time from consultation to surgery (P = 0.011). White patients were less likely to undergo biopsy versus resection (P = 0.05). EAL was negatively associated with gross total resection (P = 0.009). Chemotherapy was negatively associated with EAL (P = 0.02), Black race (P = 0.005), and public insurance (P = 0.001). Radiotherapy was negatively associated with EAL (P = 0.04), public insurance (P = 0.001), and age (P = 0.04). Clinical outcomes did not vary by sociodemographics. Interviews identified health literacy, prior healthcare experiences, and patient-surgeon connection as strongest drivers of utilization.
conclusionsDemographic factors independently associate with healthcare access but not outcomes. Progression through recommended neurosurgical-oncological care is influenced by patient-neurosurgeon relationship and trust in healthcare systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.